{
    "2019-10-21": [
        [
            {
                "time": "2019-10-21",
                "original_text": "格隆汇港股聚焦(10.21)︱中国移动前三季纯利跌14%至818亿元 石四药集团前三季纯利升17.2%至7.59亿港元",
                "features": {
                    "keywords": [
                        "中国移动",
                        "纯利",
                        "下跌",
                        "石四药集团",
                        "纯利",
                        "上升"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "电信",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-10-21",
                "original_text": "复星医药(600196.SH)：朝晖药业获药品GMP证书",
                "features": {
                    "keywords": [
                        "复星医药",
                        "朝晖药业",
                        "GMP证书"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-10-21",
                "original_text": "如何看待骨科企业股价屡创新高？",
                "features": {
                    "keywords": [
                        "骨科企业",
                        "股价",
                        "创新高"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-10-21",
                "original_text": "8省确定“4＋7”扩围时间，药企开始加速创新升级",
                "features": {
                    "keywords": [
                        "4+7扩围",
                        "药企",
                        "创新升级"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-10-21",
                "original_text": "石药集团(01093)、石四药集团(02005)、中国旭阳集团(01907)、21世纪教育(01598)实地调研",
                "features": {
                    "keywords": [
                        "石药集团",
                        "石四药集团",
                        "中国旭阳集团",
                        "21世纪教育",
                        "实地调研"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "化工",
                        "教育"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-10-02",
                "original_text": "智通港股通持股分析|10月2日",
                "features": {
                    "keywords": [
                        "港股通",
                        "持股分析"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}